Carisma Therapeutics, Inc. (SESN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Carisma Therapeutics, Inc. (SESN)
Go deeper and ask any question about SESN
Company Performance
Current Price
as of Sep 13, 2024$1.02
P/E Ratio
N/A
Market Cap
$42.38M
Description
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Metrics
Overview
- HQPhiladelphia, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerSESN
- Price$1.02+4.03%
Trading Information
- Market Cap$42.38M
- Float51.14%
- Average Daily Volume (1m)156,988
- Average Daily Volume (3m)815,233
- EPS-$1.78
Company
- Revenue$20.71M
- Rev Growth (1yr)158.34%
- Net Income-$11.16M
- Gross Margin97.23%
- EBITDA Margin-124.12%
- EBITDA-$11.42M
- EV$26.54M
- EV/Revenue1.28
- P/EN/A
- P/S2.05
Documents
SEC Filings
Factset Street Account
Factset